"Designing Growth Strategies is in our DNA"

Fibromyalgia Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Antidepressants, Antiepileptic, Muscle Relaxants, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Regional Forecast, 2020-2027

Last Updated: April 29, 2024 | Format: PDF | Report ID: FBI105016



Play Audio Listen to Audio Version

The global fibromyalgia treatment market size stood at USD 1,918.1 million in 2019. The global impact of COVID-19 has been unprecedented and staggering, with fibromyalgia drugs witnessing a negative demand shock across all regions amid the pandemic. Based on our analysis, the global market exhibited a huge decline of -60.5% in 2020. The market is projected to grow from USD 764.1 million in 2020 to USD 1,414.4 million in 2027 at a CAGR of 9.2% in the 2020-2027 period. The sudden rise in CAGR is attributable to this market’s demand and growth, new product launches, thereby returning to pre-pandemic levels once the pandemic is over.

Fibromyalgia is a musculoskeletal disorder categorized by prominent pain that is usually accompanied by sleep, fatigue, mood swings, and memory loss. There are currently only three drugs that are specifically approved for the treatment of fibromyalgia. Hence, there is higher adoption of off-label products for the management of the disease. However, increasing research and development in pain management is estimated to bolster the adoption of approved drugs for the disease indication. For instance, according to clinicaltrials.gov, around 21 clinical trials are currently conducted across different stages to assess treatment options for fibromyalgia.

Lower Number of Patients Availing Treatment to Impact Market amid COVID-19

The sudden outbreak of COVID-19 in several countries has significantly impacted pharmaceutical companies' revenue and operational capabilities. Since fibromyalgia is a lesser-known and underdiagnosed indication, the lower number of patients availing treatment for the disease due to the pandemic has had a negative impact on the market. Additionally, the key players' shifting focus towards the production of COVID-19 medicine and preventative vaccines has impacted the supply and demand of fibromyalgia treatment.


Request a Free sample to learn more about this report.

Robust Efforts by Key Players for Mergers and Acquisitions to Fuel Demand

Fibromyalgia treatment drugs exhibits enormous market growth prospective in the upcoming years attributed to rising incidence of the disease indication. Key players recognize this market potential and they are keenly engaging in the expansion of pre-marketed products in the industry. For instance, Teva Pharmaceuticals AJOVY which is already approved in the U.S for migraine is currently under phase 2 clinical trial for the management of fibromyalgia. This essential trend is expected to influence the market growth during the forecast period positively.


Increasing Prevalence of Fibromyalgia to Favor Market Expansion

Numerous factors drive the global fibromyalgia treatment market growth. Though, the leading characteristic that is anticipated to augment the market is the worldwide increase of fibromyalgia. Stated by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), approximately five million individuals aged 18 years or over in the U.S. suffer from fibromyalgia. Additionally, over 80 to 90 percent of fibromyalgia patients are females.

Additionally, the increasing government initiatives that guide manufacturers and healthcare professionals regarding fibromyalgia are estimated to augment market growth. For instance, the European League Against Rheumatism (EULAR) issued a recommendation in their 2016 guidelines against using non-steroidal anti-inflammatory drugs (NSAID) to treat fibromyalgia. Such policies are estimated to increase awareness and help manage fibromyalgia among the affected population.

Strong Pipeline Products to Boost Market

Established players dominating the market are actively engaging in the launch of innovative fibromyalgia treatments to establish or retain their market position. Impending launches and authorizations that focus on the treatment of fibromyalgia are projected to boost the market growth over the forecast timeframe. For example, as of January 2021, Galcanezumab, developed by Eli Lilly and Company, is currently under a phase 4 clinical trial. The drug is approved for migraine and cluster headache and is estimated to reach its pivotal clinical end-stage in December 2021 for the treatment of fibromyalgia.


Higher adoption of Off-label and Generic Drugs to Hamper Market Growth

Currently, there are only three drugs explicitly approved for the treatment of fibromyalgia. This has led to higher adoption of off-label drugs and generic antidepressants to manage the disease's indication. Additionally, Pfizer lost the patent protection rights of Lyrica in June 2019. This patent expiration has significantly impacted the revenue generated by the drug in the market. Generic competition is estimated to restrain the growth of the market in the foreseen years.


By Drug Class Analysis

To know how our report can help streamline your business, Speak to Analyst

Antiepileptic Drugs Held Highest Market Share in 2019

On the basis of drug class, the market is categorized into antidepressants, antiepileptic, muscle relaxants, and others (incl. pipeline products).

The antiepileptic ruled the market in 2019. The highest revenue generated by Lyrica marketed by Pfizer has driven the segment growth to the dominating position in the market. Lyrica, which is an antiepileptic drug, is highly adopted in the management of fibromyalgia among the population.

Muscle relaxants held the second-largest share in 2019. The segment is estimated to show slower growth, mainly attributed to possible product launches of pipeline products in the market. However, the product type is considerably adopted in developing regions such as Latin America and the Middle East, and Africa.

By Distribution Channel

Growing OTC Products to Drive the Growth of the Retail Segment

Based on the segmentation of distribution channels, the fibromyalgia treatment market includes hospital pharmacies, retail pharmacies, and online pharmacies.

The ease of availability of fibromyalgia drugs in retail and hospital pharmacy is estimated to drive the segment's growth over the forecast period. Additionally, fibromyalgia treatment doesn’t require hospitalizations thus attributing higher market share for the retail pharmacies. However, increasing penetration of online pharmacies in developing countries is projected to augment the growth of others.


North America Fibromyalgia Treatment Market Size, 2019 (USD Million)

To get more information on the regional analysis of this market, Request a Free sample

North America created a revenue of USD 1,253.5 million in 2019 and will see predominant market growth during the projected timeframe. The development is owed to the higher rate of diagnosis and prevalence of fibromyalgia combined with larger availability of advanced approved products to manage the disease.  According to the American Chronic Pain Association (2017), an estimated 2-4% of Americans have fibromyalgia. Additionally, the higher focus of key competitors to launch innovative drugs in the North American region is estimated to propel the market during the forecast duration.

Europe market growth is driven by numerous components including the rising prevalence of fibromyalgia. Additionally, the lack of treatment options for fibromyalgia and potential product launches are estimated to augment market growth in the coming years.  Furthermore, the European Commission's upturn in healthcare spending is anticipated to fuel the region's growth.

Meanwhile, the Asia-Pacific market is projected to exhibit stable growth during the forecast period. Aspects such as the rising patient population suffering from fibromyalgia, combined with increasing healthcare expenditure and advancing healthcare infrastructure are anticipated to favor market growth in Asia Pacific. The rising awareness of fibromyalgia is likely to drive the market during the forecast duration.

To know how our report can help streamline your business, Speak to Analyst

The Latin America and the Middle East & Africa market are continually participating in improving the availability of treatment options. Over the past years these regions have witnessed substantial expansions in the public and private healthcare sectors which is expected to positively influence the market growth in these regions.


Highly Consolidated Market with Three Major Players Dominating the Market

The global market exhibits significant competition in the market, with key players such Pfizer, Inc., Eli Lilly and Company, and Allergan dominating the market. Focus on mergers and acquisitions, and innovative product launches are predominant strategies adopted by these key players to secure higher customer reach. A strong lineup of pipeline products by players such as Tonix Pharmaceuticals and Teva makes them key competitors in the market. Other players in the market included in the market are Aptinyx, Novartis AG, Sun Pharmaceuticals industries, Astella Pharma Inc, among others.


  • Pfizer, Inc.(U.S.)

  • Eli Lilly and Company (U.S)

  • Allergan (Ireland)

  • Tonix Pharmaceuticals (U.S)

  • Aptinyx (U.S)

  • Teva Pharmaceutical Industries Ltd. (Israel)

  • Novartis AG (Switzerland)

  • Sun Pharmaceuticals (India)

  • Astellas Pharma Inc. (Japan)

  • Other Prominent Players       


  • December 2020: Tonix Pharmaceutical announced that the company achieved positive phase 3 study results for TNX-102 to treat fibromyalgia.

  • June 2020: Teva Pharmaceutical Industries Ltd. announced that the company would present new data regarding the AJOVY injection open-label study for migraine and fibromyalgia.


An Infographic Representation of Fibromyalgia Treatment Market

To get information on various segments, share your queries with us

The fibromyalgia treatment market research report provides qualitative and quantitative insights on this market and a detailed analysis of market size and growth rate for all possible market segments. Coupled with this, the report offers an elaborative analysis of the market dynamics and competitive landscape. Several key market insights offered in the report are the prevalence of fibromyalgia by key regions, key industry developments, key industry trends, pipeline analysis, regulatory scenario, analysis of COVID-19 on the global market, among others.

Report Scope & Segmentation



Study Period


Base Year  


Forecast Period


Historical Period



  Value (USD Million)


  Drug Class, Distribution Channel, and Region

By Drug Class


  • Antidepressants

  • Antiepileptic

  • Muscle Relaxants

  • Others (incl. Pipeline Products)

By Distribution Channel


  • Hospital Pharmacy

  • Retail Pharmacy

  • Online Pharmacy

By Geography


  • North America

    • By Drug Class

    • By Distribution Channel

    • By Country

      • USA (By Drug Class)

      •  Canada (By Drug Class)

  • Europe

    • By Drug Class

    • By Distribution Channel

    • By Country

      • UK (By Drug Class)

      • Germany (By Drug Class)

      • France (By Drug Class)

      • Italy (By Drug Class)

      • Spain (By Drug Class)

      • Scandinavia (By Drug Class)

      • Rest of Europe (By Drug Class)

  • Asia Pacific

    • By Drug Class

    • By Distribution Channel

    • By Country

      • Japan (By Drug Class)

      • China (By Drug Class)

      • India (By Drug Class)

      • Australia (By Drug Class)

      • Southeast Asia (By Drug Class)

      • Rest of Asia Pacific (By Drug Class)

  • Latin America

    • By Drug Class

    • By Distribution Channel

    • By Country

      • Brazil (By Drug Class)

      • Mexico (By Drug Class)

      • Rest of Latin America (By Drug Class)

  • Middle East & Africa

    • By Drug Class

    • By Distribution Channel

    • By Country

      • GCC (By Drug Class)

      • South Africa (By Drug Class)

      • Rest of MEA (By Drug Class)

Frequently Asked Questions

Fortune Business Insights says that the global market size was USD 1,918.1 million in 2019 and is projected to reach USD 1,414.4 million by 2027.

In 2019, the North American market size stood at USD 1,253.5 million.

The market will exhibit a stunning growth of 9.2% during the forecast period (2020-2027).

The antiepileptic segment dominated the global market in 2019.

The increasing prevalence of fibromyalgia and robust pipeline products are expected to drive the growth of the market.

Pfizer, Eli Lilly and Company, and Allergan are the major players in the global market.

North America dominated the market in terms of share in 2019.

New product launches are expected to drive the adoption of fibromyalgia treatment products.

Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts

Speak to an Expert
  • 2019-2032
    (In Process)
  • 2023
    (In Process)

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.

“Thanks a million. The report looks great!”

- Feedback from a consultant on a report on the U.S. Beef Market.

“Thanks for the excellent report and the insights regarding the lactose market.”

- Brazil based company specializing in production of protein ingredients.

“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”

- Global Digital Services Agency on a report on the Global Luxury Goods Market.

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.